Day: July 29, 2020

MIGDAL HA’EMEK, Israel, July 29, 2020 (GLOBE NEWSWIRE) — PV Nano Cell Ltd. (OTC: PVNNF), (the “Company”), an innovative provider of inkjet-based conductive digital printing solutions and producer of conductive digital inks, today announced it has opened a new site for its application team and printers. The new site will house the company’s application team to serve the increasing number of customers in need for printing solutions, process development and printing services.The new offices are located close to the company’s headquarters in Migdal Ha’Emek, Israel and host several DemonJet printers and a mass production printer. The offices are fully equipped with microscopes, sintering ovens and electrical measurement tools. The new location will also serve as a demo center for visiting customers to see the company’s...

Horizon Discovery Group plcHalf Year Trading UpdateBusiness remains robust with sustained recovery to 2019 levels as demand for Horizon’s products and services remains highGroup is confident of a return to growth in H2 2020Capital markets webinar 15:00 BST today – dial in details belowCambridge, UK, 29 July 2020: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Group” or “the Company”), a cell engineering company focused on commercialising the application of gene editing and gene modulation to accelerate scientific innovation and biopharmaceutical drug development, today provides an unaudited pre-close trading update for the six months ended 30 June 2020. The Company plans to report its half year 2020 results on 17 August 2020.FinancialsHorizon expects to report half year 2020 revenues of approximately £22.4...

AMRYT PHARMA PLC(“Amryt” or the “Company”)AMRYT TO HOST KEY OPINION LEADER CALL ON EPIDERMOLYSIS BULLOSA DISEASE LANDSCAPEMonday, August 3, 2020 at 1000 ET / 1500 BSTDUBLIN, Ireland, and Boston MA, July 29 2020, Amryt (Nasdaq: AMYT, AIM: AMYT, Euronext Growth: AYP), a global, commercial-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from serious and life-threatening rare diseases, today announces it will host a Key Opinion Leader (KOL) call on Epidermolysis Bullosa (EB) disease on Monday, August 3, 2020 at 1000 ET (1500 BST).The call will feature a presentation by KOLs Harper Price, MD (Phoenix Children’s Hospital) and Brett Kopelan (debra of America) who will discuss the current disease landscape and unmet medical need in treating patients with EB. Dr....

TORONTO, July 29, 2020 (GLOBE NEWSWIRE) — Global Atomic Corporation (“Global Atomic” or the “Company”; TSX:GLO; OTCQX: GLATF; Frankfurt: G12) announced today that significant progress has been made towards submitting it’s Mining Permit application for the Dasa Uranium Project in the Republic of Niger, West Africa. HIGHLIGHTS:In July,The Company filed its completed Environmental Impact Statement (“EIS”), with the Niger Government;The Dasa Project site hydrogeology drilling and water flow test work has been completed; andA tender for final geotechnical diamond drilling for the feasibility study has been issued.In August,Two public hearings in Niger regarding the EIS are being scheduled; one in the Dasa Project area and the other in the capital city of Niamey;the Company will begin a Pilot Plant test program to confirm Dasa process...

RAMSEY, N.J. and BOCA RATON, Fla., July 29, 2020 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced the Company will host a live conference call and audio webcast on Wednesday, August 5, 2020 at 4:30 p.m. ET, to discuss its business highlights and financial results for the second quarter ended June 30, 2020.To access the conference call, please dial (855) 884-8773 (local) or (615) 622-8043 (international) at least 10 minutes prior to the start time and refer to conference ID 8992308. A live audio webcast of the call will be available under “Events & Webcasts” in the investor section of the Company’s website, https://ir.admabiologics.com/events-webcasts. An...

RIDGEFIELD, Conn., July 29, 2020 (GLOBE NEWSWIRE) — The Chefs’ Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs’”), a premier distributor of specialty food products in the United States and Canada, today reported financial results for its second quarter ended June 26, 2020.Financial highlights for the second quarter of 2020 compared to the second quarter of 2019:Net sales decreased 51.3% to $200.5 million for the second quarter of 2020 from $411.4 million for the second quarter of 2019.GAAP net loss was $20.3 million, or $(0.57) per diluted share, for the second quarter of 2020 compared to net income of $7.7 million, or $0.26 per diluted share, in the second quarter of 2019.Adjusted EPS1 was $(0.52) for the second quarter of 2020 compared to $0.33 for the second quarter of 2019.Adjusted EBITDA1 was $(13.7) million for the...

CRESSKILL, N.J. and JERUSALEM, Israel, July 29, 2020 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders, today announced that it will report its second quarter 2020 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, August 12, 2020. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.Conference Call Dial-In & Webcast Information:The conference call will be broadcast live and will be available for replay for 30 days on the Company’s website, https://investors.brainsway.com/financial-calendar. Please access the Company’s website at least 10 minutes ahead of the conference...

New York, July 29, 2020 (GLOBE NEWSWIRE) —Second quarter reported net revenue of $1.85 billion, a decrease of 12.8% from a year ago, with organic net revenue decrease of 9.9%, due to impact of global economic contraction in the quarterFirst half reported net revenue decrease of 7.4%, and organic net revenue decrease of 5.0%Second quarter reported net loss was $45.6 million including restructuring charges, and adjusted EBITA was $174.9 million before restructuring chargesSecond quarter adjusted EBITA margin of 9.4% before restructuring chargesSecond quarter diluted loss per share of $0.12 and diluted earnings per share of $0.23 as adjustedFirst half diluted loss per share of $0.11 and diluted earnings per share of $0.34 as adjustedManagement initiated program of extensive structural operating cost reduction, resulting in restructuring...

Hexagon Purus, a subsidiary of Hexagon Composites, has been awarded a contract for the design, development, qualification and production of high-performance Type 4 composite pressure vessels to a new major aerospace customer for its launch vehicle. The total sales value of the current order is approximately USD 5.2 million (approx. NOK 48 million). Future orders are expected to follow the successful delivery of the first shipment.Driving energy transformationThis is the second project that Hexagon Purus has collaborated on in the aerospace industry in the past two years. Hexagon Purus’ smart technology combined with its world leading expertise in lightweight, reliable and safe high-pressure gas storage is being leveraged to support pioneering developments in space travel.“We are excited to be working on this project and to be partners...